New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial
ScienceDaily | Mesothelioma News
by
2M ago
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options ..read more
Visit website
High lung cancer rates in naval veterans linked to asbestos
ScienceDaily | Mesothelioma News
by
5M ago
A new study has discovered asbestos exposure led to a higher incidence of asbestos-related lung cancers in British and Australian naval personnel than in other armed forces ..read more
Visit website
Pleural mesothelioma: New therapeutic approach to enhance sensitivity to chemo- and radiotherapy
ScienceDaily | Mesothelioma News
by
6M ago
Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study identified the oncoprotein YB-1 as an attractive therapeutic target in PM and demonstrates that indirect targeting of YB-1 is a promising approach to enhance sensitivity to chemo- and radiotherapy ..read more
Visit website
'Drug factory' implants eliminate mesothelioma tumors in mice
ScienceDaily | Mesothelioma News
by
1y ago
Researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining tiny, cytokine 'drug factory' implants and a checkpoint inhibitor drug ..read more
Visit website
Study shows critical protein may play a role in origin of mesothelioma
ScienceDaily | Mesothelioma News
by
2y ago
Researchers have discovered that a protein critical in the embryonic stages of life is reactivated in certain cases of mesothelioma, offering clues into the origin of this aggressive cancer ..read more
Visit website
Immunotherapy-chemotherapy treatment coupled with in-depth genomic analyses leads to improved survival for patients with mesothelioma
ScienceDaily | Mesothelioma News
by
2y ago
Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural mesothelioma, a cancer of the tissues lining the lungs, according to a phase II clinical trial ..read more
Visit website
Drug combination shows meaningful responses for malignant peritoneal mesothelioma patient
ScienceDaily | Mesothelioma News
by
3y ago
A phase II study found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective response rate in patients with advanced malignant peritoneal mesothelioma, a rare cancer in the lining of the abdomen ..read more
Visit website
Overlooked lymph nodes in rib cage have prognostic power for mesothelioma patients
ScienceDaily | Mesothelioma News
by
3y ago
For the first time, researchers have shown the predictive power of a group of overlooked lymph nodes that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma ..read more
Visit website
Strategy to expand patient participation in hard-to-enroll clinical trials
ScienceDaily | Mesothelioma News
by
3y ago
Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases ..read more
Visit website
Mesothelioma: Two groundbreaking trials into treatments for asbestos-related cancer
ScienceDaily | Mesothelioma News
by
3y ago
Two major trials are looking into treatments for a type of cancer which affects those exposed to asbestos ..read more
Visit website

Follow ScienceDaily | Mesothelioma News on FeedSpot

Continue with Google
Continue with Apple
OR